Arrhythmias that occur during the early stages of acute myocardial ischemia have been attributed to both reentrant and nonreentrant mechanisms. Inhomogeneities in conduction and refractoriness contribute to the development of reentrant arrhythmias,' whereas injury currents generated by inhomogeneous changes in the resting potentials of cells within the ischemic zone may contribute to the development of nonreentrant arrhythmias.2 One possible explanation for these electrical inhomogeneities is the inhomogeneous rise in [K']e after the onset of coronary occlusion. Potassium inhomogeneities have been observed within (microinhomogeneities) and between (macroinhomogeneities) discrete regions of the ischemic myocardium. [3] [4] [5] [6] [7] We have hypothesized that the ionic inhomogeneities within and between ischemic regions are of sufficient magnitude to cause the observed electrical inhomogeneities. The recent study by Coronel et al, 7 in which the inhomogeneities were determined at a single point in time and expressed semiquantitatively, supports this hypothesis.
In this study, we have attempted to delineate rigorously the magnitude and time course of the inhomogeneities of the rise in [K']e in the center and margin of the ischemic zone after acute ligations of the left anterior descending coronary artery (LAD) in the anesthetized open-chest pig. We used multiple, K'-sensitive electrodes placed closely together within the center or at the lateral margin of the ischemic zone to measure the changes in [K']e. Specific electrode calibration and performance criteria, including preexperimental and postexperimental calibration standardization and in situ response characteristics were developed to guarantee the accuracy of the data. Comprehensive statistical methodologies were applied to identify the most appropriate measure of the inhomogeneities and to determine the number of electrodes necessary to measure it. We also examined the effect of verapamil on these inhomogeneities because this drug, when administered before coronary occlusion, prevents ventricular fibrillation during the occlusion.8 '9 In brief, we found that 1) 12-20 equivalent measurement sites within an ischemic region of the heart are necessary to optimally estimate potassium inhomogeneity, 2) the statistical measure of standard deviation produces the most reliable, unbiased estimate of this potassium variability, 3) potassium inhomogeneity is greater in the lateral margin than in the center of the ischemic region, and 4) verapamil, an antifibrillatory agent, significantly attenuates the magnitude and variability of potassium change in both ischemic regions without altering the relations between them.
Methods Electrode Fabrication and Calibration
Miniature K'-sensitive plunge-wire electrodes were fashioned by methods previously described.10"11
In brief, cut ends of Teflon-coated silver wires (0.007-in. diameter) were chloridized and covered with a cellulose acetate-titanium dioxide sponge mixture.
The K'-sensitive electrodes were made by covering the tip with a polyvinyl chloride-valinomycin membrane and by hydrating them in 3 mM KCI. The reference electrodes lacked the polyvinyl chloridevalinomycin membrane. All electrodes were "hooked" by forming a 45-90°angle between the electrode wire and the ion-selective tip. Two K+-sensitive electrodes and a reference were loaded into each 20-gauge hypodermic needle that was subsequently used to insert the electrodes into the myocardium. Withdrawal of the needle after insertion left the electrodes embedded in the myocardial tissue. Dual loading of the K'-sensitive electrode limited myocardial damage during the placement of the large numbers of electrodes used in these studies.
Critical electrode assessments are mandatory to ensure the elimination of inaccurate estimates of potassium inhomogeneity introduced by differences in electrode response characteristics from one placement site to another. Therefore, the electrodes were calibrated and evaluated both in vitro and in vivo. The in vitro calibration was performed before the insertion of the electrodes into the myocardium. The in vivo verifications of electrode performance and calibration were performed while the electrodes were in the heart muscle.
The in vitro calibration of the K'-sensitive electrodes was done before each experiment by alternately placing the electrodes in solutions of 3 and 10 mM KCl. Electrodes were inserted into the heart muscle only when they demonstrated a stable baseline (drift, <1 mV/hr) and a Nernstian slope±5% (56-62 mV/decade change in [K'] at 24°C) in the preexperimental in vitro calibration.
The in vivo performance of each K'-sensitive electrode was determined before each control and verapamil occlusion by the rapid intravenous 1.5-ml bolus injection of a solution containing 2 meq KCl/ml through a catheter positioned near the terminal portion of the inferior vena cava. The response of implanted electrodes typically fell into one of the three categories identified as types A, B, and C ( Figure 1 Right atrial pacing was used as needed after the femoral vein was cannulated and was used verapamil administration to match the spontaneous ,sion of 0.9% saline solution (125 ml/hr), heart rate of the previous control occlusion. The Center Experimental Protocol FIGURE 2. Schematic of the pig heart that identifies the location ofthe ischemic zone (shaded) to the visible cyanotic border (solid line). Electrodes are shown as solid bullets. Dashed line indicates the interior 5 mm of the cyanotic border used as an interior reference for electrode placement in the marginal zone. Marginal electrodes were not placed more than 2 mm outside of the cyanotic border. Central electrodes were placed more than 10 mm inside this border. All electrodes were located in the midmyocardium more than 3 mm from the subendocardium and subepicardium. Electrode placements and estimates of the extent of myocardial ischemia were determined by injecting thioflavin S (1 g) intravenously into the heart with the LAD occluded for 30 seconds before death. Subsequent dissection permitted the determination of electrode positions within and in relation to the ischemic border. Electrodes that were within 3 mm of the endocardium or epicardium and those not satisfying the location restraints were eliminated from further study. On average, 17 electrodes in each experiment fulfilled the calibration and location requirements. In four randomly selected preparations from both protocols, we divided the heart ventricles into left or right and ischemic or nonischemic portions. We found no statistical differences between the two protocols for the degree or distribution of the ischemia produced by LAD ligation.
Statistical Analysis
We compared the results of the third and fourth sequential control occlusions by placement location for the control protocols (C3 and C4 for central and marginal electrode locations) to demonstrate the reproducibility of the results in the fourth occlusion. We then compared the results of the preverapamil control occlusion (C3V) to the subsequent occlusion performed after the administration of the drug (V). To verify the equivalency of the third occlusion between those animals given drugs and those not treated, we compared the results of the C3V occlusions to the C3 occlusions and the results of the C4 occlusions to the V occlusions in the two protocols by placement location. Statistical analysis was performed with t tests for paired data within a protocol (C3 versus C4 or C3V versus V) and two-way analysis of variance for unpaired data between protocols (C3 versus C3V or C4 versus V). A probability value less than 0.05 was considered statistically significant in all tests. Without exception, the statistical significance or insignificance of t tests on mean data at each minute within a protocol (see "Results") was confirmed by analysis of variance between protocols using the averaged data collected during the entire occlusion. The summary data shown (Figures 4, 5 , and 7-10) were calculated as follows: the mean Figure 3 demonstrates the results of representative experiments in the central and marginal ischemic zones in the control group. In the center of the ischemic zone, the change in EK recorded from the 16 acceptable electrodes 10 minutes after the start of the C3 occlusion ranges from 25 to 35 mV. Some electrodes demonstrate the onset of a plateau in the change in EK as early as 5 minutes into the occlusion, whereas others show a continuous rate of rise that slows during the second half of the occlusion. These changes were reproduced in C4. At the lateral margin of the ischemic zone, the maximum change in EK recorded from the 15 acceptable electrodes during C3 ranges from 0 to 30 mV. Most of the electrodes demonstrate a plateau in the change in EK at 5-6 minutes after the start of the occlusion. These changes were also reproduced in C4.
The mean changes in EK in the center and the margin of the ischemic zone during C3 and C4 are shown in Figure 4 . As mentioned previously, the change in EK at each time interval was first averaged for each animal at 1-minute intervals, and the mean of the averages was then calculated to obtain the values shown. For the center of the ischemic zone, the maximal mean changes in EK are 31.5+1.5 and 29.5+1.6 mV for C3 and C4, respectively. The values do not differ significantly at any time during the occlusion. For the margin of the ischemic zone, the mean changes in EK during C3 and C4 also do not differ at any time. Maximum values for the mean changes in EK are 19.5 +3.6 and 19.1+4.3 mV for C3 and C4, respectively.
The average standard deviation of the change in EK at each time interval during C3 and C4 is shown in Figure 5 . In the center of the ischemic zone, the peak average standard deviations of the change in EK are 6.6±0.2 and 5.9±0.5 mV for C3 and C4, respectively.
These peak values occur between 4 and 5 minutes after the onset of the occlusion. Thereafter, the average standard deviations decrease significantly to 4.8±0.7 and 4.2±0.9 mV for C3 and C4, respectively. There were no significant differences between the mean standard deviations of the change in EK at any time during C3 and C4. In the margin of the ischemic zone, the peak average standard deviations of the changes in EK are 8.2±2.3 and 7.9±3.0 mV for C3 and C4, respectively. These peak values occur between 9 and 10 minutes after the start of the occlusion; however, unlike the standard deviations for the central zone, those for the marginal zone at 4 minutes into the occlusion are not different from these maximum values (7.4±1.3 and 7.3±1.7 at 4 minutes in C3 and C4, respectively). There were no significant differences between the average standard deviations of the change in EK at the margin at any time during C3 and C4.
The results shown in Figures 3-5 confirm the reproducibility of the changes in EK and the standard deviation of the change in EK at the center and margin of the ischemic zone. Figures 6-8 The mean changes in EK before and after verapamil administration from all experiments are shown in Figure 7 . In the center of the ischemic zone during C3V, the mean changes in EK reach a maximum of 31.1±+-6.7 mV, similar to that observed in C3 (31.5±1.5 mV). After verapamil administration, the mean changes in EK increase more slowly and reach a maximum of 21.9±5.3 mV. The differences between C3V and V were significant from 1 to 7 minutes after the beginning of the occlusion. In the margin of the ischemic zone, the mean changes in EK during except the third control occlusion (EKIC3v) for preparations in the center (n=3) and margin (n=4) of the ischemic zone is followed by a verapamil occlusion (EKIV). Values are the mean change in EK±SD for each minute of the occlusion. EK, potassium equilibrium potentiaL 1 2 3 4 5 6 7 8 9 10 Time (min) is similar to that observed during C3 (19.5+±3.6 mV). After verapamil administration, the mean changes in EK increase more slowly and reach a maximum of 14.6+2.9 mV. The differences between C3V and V are significant between 2 and 7 minutes after LAD ligation.
The average standard deviations of the change in EK at each time interval before and after verapamil administration are shown in Figure 8 . In the center of the ischemic zone during C3v, the mean standard deviations of the change in EK reach a maximum of 4.1 +±1.3 mV at 3 minutes after the beginning of the occlusion, are sustained until 6 minutes, and then decrease gradually to 3.7+0.8 mV at the end of the occlusion. This pattern is not substantially different than that recorded during C3. After verapamil administration, the maximum mean standard deviation of the change in EK is also 4.1±2.6 mV. However, it occurs 6 minutes after the start of the occlusion. Thereafter, mean standard deviations decrease to 3.2±0.9 mV by the end of the occlusion. Between 2 and 4 minutes after LAD ligation, two-way analysis of variance reveals that the standard deviations were significantly reduced by verapamil. In the margin of the ischemic zone during C3v, the standard deviations were at their maximum 5 minutes after the start of occlusion (8.5±1.1 mV) and remained at this level throughout the remainder of the occlusion. This is also similar to the pattern of change that was recorded during C3. After verapamil administration, the maximum standard deviation was 7.4±0.9 mV. However, this maximum value was not observed until 9 minutes after the start of occlusion. The differences in the mean standard deviations for C3V and V were significant during the first 6 minutes of the occlusion. We determined the coefficients of variation for C3V
and V (i.e., the standard deviation divided by the mean) at each minute during the occlusion. These results are shown in Figure 9 . In the absence and the presence of verapamil, the coefficients of variation were greatest in the first minute after occlusion and then decreased curvilinearly during the remainder of the occlusion. In the center of the ischemic zone, the coefficients of variation before verapamil administration average 0.72±0.15 at 1 minute after the beginning of the occlusion and decreased to 0.12±0.01 at 10 minutes. After the administration of verapamil, the coefficients of variation at Figure  10 , where these two parameters have been plotted against each other without respect to time. In the 
Discussion
In these studies, we attempted to quantify the magnitude and time course of the microinhomogeneities of the change in EK in the midmyocardium of the central and lateral margin of the ischemic zone during acute 10-minute occlusions of the LAD in the in situ pig heart. Also, we assessed the effects of verapamil on these parameters. We postulated that these inhomogeneities will provide insight into the cause of previously described electrical inhomogeneities6 and that these inhomogeneities may underlie the critical events that lead to ventricular fibrillation and sudden cardiac death.
Existence of Microinhomogeneities
The presence of differences in the rate and mag- showed that the inhomogeneity is greater in the margin than in the center and that verapamil reduces the inhomogeneity of the EK change in both zones. Our confidence in these results is strengthened by our application of strict electrode calibration, response, and location criteria, thereby eliminating the possibility that the inhomogeneities are due to differences in electrode response or inappropriate electrode placement. We did not accept electrode data that deviated by more than 5% from the Nernstian calibration response in vitro or by more than 15% from the Nernstian calibration response in vivo. We used the in vivo calibration slope of each individual electrode to calculate the changing EK recorded from that electrode rather than assuming a typical calibration slope. We rejected data from electrodes that did not demonstrate a reproducible response to repeated in vivo boluses of potassium. Last, the postexperimental determination of the location of each electrode within the myocardium allowed us to exclude electrodes that were inappropriately placed. The application of these calibration, response, and placement criteria eliminated 50% of the total electrode data but substantially improved our confidence in the existence of the inhomogeneities.
Measurement of Microinhomogeneity
Several statistical parameters can be used to assess microinhomogeneities. These include the standard deviation, variance, standard error, and the coefficient of variation. We chose to use standard deviation because it has a time course that closely resembles the changes in EK, uses the same units of measure, and provides a direct correlation to the changes in resting membrane potential.14 Our conclusions concerning the magnitude and time course of the inhomogeneities would have been somewhat different had we selected an alternative index, although the reproducibility of the results and the effect of verapamil would have remained essentially the same. The use of variance would have introduced a squared term, thus changing the units of measure to millivolts squared and "exploding" the data at higher EK values. The use of standard error would have attenuated the measurement through the division of the standard deviation by the square root of the number of electrodes used, thereby sensitizing the measure to the number of electrodes used in each study. We also calculated the coefficient of variation by dividing the standard deviation at each minute by the change in EK at that time. The effect of this manipulation is to express the variability as a fraction of the mean, thereby allowing comparisons between ischemic zones when neither the change in EK nor the standard deviation of the change have the same order of magnitude. This method produces a dimensionless value in which the absolute magnitude of the numerator and denominator are lost. Although the coefficient is of value in relating the mean and standard deviation near the end of the ischemic episode, we found the coefficient to be limited, if not misleading, during the initial phase of the occlusion. For example, the high value of the coefficient of variation recorded 1 minute after the start of the occlusion in the center and the margin of the ischemic zone during the control and verapamil occlusions is due to the relatively small change in EK rather than to a large change in standard deviation. Thus, this numerical expression of variability obscures the fact that both the change in EK and the standard deviation of the change are quite small initially and are likely to have little physiological significance. For these reasons, we do not consider the coefficient of variation trodes at probability levels of 80% (a or a=0.10) and 90% (a or a=0.05) for marginal electrode placements at 10 minutes after left anterior descending coronary artery occlusion.
to be a useful index of inhomogeneity in most circumstances. Rather, we believe that the standard deviation of the change in EK, when viewed in light of the magnitude of the EK change, is the most useful and the most physiologically significant measure of the inhomogeneity in [K']e associated with ischemia.
The calculation of the minimum number of measurement sites required to accurately estimate inhomogeneity is not direct. The ratio of measured to true variance has a x2 distribution as shown below15: X20.05/(n _ 1) C [S2/u2] <X20.95/(n -1) where x2 is the upper and lower x2 value for a specified probability interval (e.g., 90%, a=0.05), n is the number of measurement sites, s is the measured standard deviation, and o-is the true standard deviation. Through this probability interval for the s2/1o2 ratios, the x2 tables can be used to calculate the expected percentage of overestimation or underestimation that s2 represents relative to the true variability for selected values of n and specified probability levels. We calculated these percentages for n ranging from 5 to 36 at probability levels of 90% (a=0.05) and 80% (a=0.10). These percentages are summarized in Figure 11 .
Examination of this figure reveals two details: 1) As the number of measurement sites used to calculate variability becomes larger, the range of overestimation and underestimation of true variability becomes narrower. 2) As the probability level allowed becomes smaller, fewer measurement sites are required to attain a given range of overestimation and underestimation of true variability. After an n of 12, the improvement in the estimate of true variability at larger sample sizes begins to level off. For example, at n equal to 12, estimates of true variability are about +25% for the 0.80 probability level and ±35% for the 0.90 probability level. At n equal to 20, these probability levels decrease to ±20% and ±+25%, respectively. In cases where the true variability is less (e.g., in the central ischemic region or after the administration of verapamil), narrower ranges of underestimation and overestimation of variability will occur for each value of n because of the reduced variability of the population for which the estimate is being calculated. In summary, our results suggest that 12 We found that the changes in EK and in the standard deviation of the changes in EK were reproducible in the third and fourth control occlusions. This finding was expected on the basis of our earlier studies.4 However, fewer electrodes were used in those earlier studies, and the procedures used to calibrate the electrodes were less rigorous. For these reasons, we believed it important to confirm the reproducibility of the inhomogeneities before assessing the effects of verapamil. We confirmed the finding that verapamil lessened the change in EK during the occlusion. We also observed that verapamil reduced the inhomogeneity of the change in EK during the first 4 minutes of the occlusion in the center and during the first 6 minutes in the margin of the ischemic zone.
This work directly follows from our previous study,7 which was designed to relate the inhomogeneities in [K']e to electrophysiological variables. In that study, inhomogeneity during regional ischemia was determined at a single point in time measured 7-10 minutes after occlusion and was expressed as the coefficient of variation. In addition, 10-mV EK response bands were used to map the changes in EK. In the present study, our intent was to quantify the magnitude of the microinhomogeneities and to determine the time course of their development. For these reasons, we did not partition the changes in EK into 10-mV bands, and we determined the inhomogeneities at each minute during the occlusion. In both studies, data were expressed as the change in EK, and special care was applied in validating the performance of the electrodes, including an in situ calibration. We now conclude that standard deviation is a more appropriate and better physiological marker of the inhomogeneity than is the coefficient of variation, especially during the early portion of the occlusion, provided that an adequate number of electrodes are used in each region. Moreover, we conclude that the coefficient of variation masks a more subtle relation between the mean change in EK and the mean standard deviation of the change in EK, thus indicating that the variability of changes in EK must be viewed in light of the magnitude of the change in EK.
Cause of the Inhomogeneities
The mechanisms underlying the development of the microinhomogeneities, particularly those in the center of the ischemic zone, are not intuitively obvious. Several mechanisms can be postulated. These include the diffusion of potassium into regions having less potassium efflux, The anatomic nature of the border may also contribute to the microinhomogeneities that we have observed. It is known that the margin is composed of interdigitating islands of normal and ischemic cells.1617 The electrodes labeled as "margin" on the basis of their anatomic relation to the lateral cyanotic border may sample regions from both normal and ischemic cells. Those in or closest to normal cells will record lower levels of [K+]e than those in or closest to ischemic cells. This mechanism is obviously more applicable to the inhomogeneities observed in the margin than to those observed in the center and, in combination with the effects of diffusion, may help to explain the greater standard deviation of the changes in EK observed at the margin than in the center of the ischemic zone.
The efflux of potassium from ischemic cells was recently linked to the rise in Pco2 in the ischemic region.18 In areas closest to the lateral margin and to the ventricular chamber, carbon dioxide will diffuse away from the ischemic zone. This factor will lessen the rise in [K+]e regardless of any effect of potassium diffusion. Again, this effect would be expected to contribute to the lower changes in EK at the lateral margin and in the subendocardial border region. In addition, the diffusion of oxygen into each of these regions would be expected to lessen the effects of ischemia and lead to a lesser rise in Pco2 and a lesser rise in [K+] e. Although these events may help to explain the differences in the changes in EK between the center and margin and may contribute to the microinhomogeneities present in the margin, they do not readily explain the microinhomogeneities in the change in EK present within the midmyocardium of the center of the ischemic zone. A possibility that cannot be excluded on the basis of our study is that the cells in the midmyocardium of the center of the ischemic zone respond to the abrupt cessation of coronary flow at slightly different rates, leading to slightly dissimilar rates of the free energy of ATP hydrolysis,19 the rate of development of intracellular acidosis,4 or the appearance of ionic or metabolic compartments.20 Because the rise in intramyocardial [K']e has been attributed to these mechanisms, minor differences in the time course of these events may explain the microinhomogeneities in the changes in EK that we have observed in the center of the ischemic zone and may contribute to the microinhomogeneities in the margin.
Effect of Microinhomogeneities
Our findings indicate that within the midmyocardium of the center of ischemic zone, the changes in EK after coronary occlusion may range from 20 to 35 mV. In the lateral margin, the changes may range from 0 to 30 mV. Kleber14 showed that during ischemia, the changes in EK predict the changes in resting membrane potential. If the resting potential of the myocardial cells is assumed to be -85 mV in the control preocclusion period, then resting potentials ranging from -65 to -50 mV will occur simultaneously in closely spaced cells within the center of the ischemic zone and from -85 to -55 mV in the cells within the lateral margin. These differences in resting potential will result in significant differences in the magnitude of the inward sodium current, the rate of rise of the action potential upstroke, the time constant of the recovery of excitability, and the action potential duration. In addition, the rates at which intracellular and extracellular resistances change may also vary.21 As a result, significant differences in conduction velocity and refractoriness within closely spaced regions will occur. These differences may contribute to the development of the intramural reentry circuits recently described by Pogwizd and Corr.22 If the changes in the subendocardial border described by Wilensky et a15 are similar to those that we and Coronel et a17 observed at the lateral margin, then macroreentry and microreentry circuits may be expected to occur in the lateral and subendocardial borders. The differences in EK (and resting potential) between closely spaced myocardial elements may also lead to local injury currents that either add to or detract from the more global injury currents generated across the various border regions.2,23 These local injury currents may contribute to the lack of correlation between the changes in EK and changes in the TQ potential of the local electrogram.67 They may also contribute to the development of spontaneous depolarization and triggered activity within the center of the ischemic zone, and thereby be one cause of the nonreentrant spontaneous beats and rhythm observed. 22 The magnitude of the microinhomogeneities as expressed by the standard deviations of the change in EK peaked within the first 5 minutes of the occlusion then decreased in the center or remained constant at the margin. This finding provides at least a temporal correlation between the development of inhomogeneities and the onset of ventricular arrhythmias that occur in the first 5 minutes of a coronary occlusion as determined by Kaplinsky et al. 24 By so doing, it lends credence to the argument that the microinhomogeneities may be one cause of these arrhythmias.
Effect of Verapamil
In this study, as in our previous work,12 we found that verapamil slowed the rate of rise of [K']e after LAD occlusion in the center and the margin of the ischemic zone. Using an isolated papillary muscle preparation, Cascio et a125 showed that verapamil also postpones cell-to-cell uncoupling, the secondary rise in [K']e, and the onset of ischemic contracture while decreasing the rate of uncoupling and contracture. This study adds to these observations by showing that verapamil also slows the rate at which the inhomogeneities in the change in EK develop. Whether this represents an important mechanism underlying the known antifibrillatory effect of verapamil89 cannot be determined from this study because calcium channel blockade exerts several additional effects that may be of equal or greater significance. These include the slowing of the rate of rise of [K] ,12,26 a decrease in the fall in pH,12 suppression of action potentials dependent on the calcium inward current,27 the preservation of energy stores,28 and mitochondrial protection.29 Our observation that verapamil does not alter the relation between the mean change in EK and the mean standard deviation of the change in EK (Figure 10 ) strongly suggests that the antiarrhythmic effects attributed to verapamil are more likely due to the time shift of the change in EK and the standard deviation of the change in EK than to the actual reduction in the magnitude of either parameter. Indeed, previous work using this same animal model30 has shown that the plateau levels of [K+]e during 60-minute occlusions is the same in both ischemic zones after treatment with verapamil compared with those of the control, although verapamil significantly delays the time at which the plateau occurs. Nevertheless, if the microinhomogeneities in EK do contribute to the early arrhythmias after coronary occlusion, then it is reasonable to speculate that the lessening of these inhomogeneities is an important antiarrhythmic effect.
